Medtronic evaluating manufacturing footprint amid higher tariffs: report
Medtronic (MDT) is reportedly looking at adjusting its global manufacturing footprint amid heightened concerns that the U.S.
Distributor Purchasing Shifts Mar MDT's Q3 Show: How to Play the Stock
Medtronic's Medical Surgical segment faces challenges in the third quarter due to shifts in U.S. distributor buying patterns.
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI) for patients with Parkinson’s ...
Medtronic’s Expansion Gains Momentum—Time for a Market Shift?
Medtronic’s (NYSE: MDT) growth efforts and investments in medical technology innovation are starting to pay off. The ...
Truist Financial Keeps Their Hold Rating on Medtronic (MDT)
Truist Financial analyst Richard Newitter maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $93.00.
Medtronic price target raised to $85 from $83 at Goldman Sachs
Goldman Sachs analyst David Roman raised the firm’s price target on Medtronic (MDT) to $85 from $83 and keeps a Sell rating on the shares. The ...
Medtronic plc (NYSE:MDT) Q3 2025 Earnings Call Transcript
Q3 2025 Earnings Call Transcript February 18, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.39, ...